Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1984 Oct;30:2133–2136.

Teratogenic Risk of Drugs Used in Early Pregnancy

John Ruedy
PMCID: PMC2154342  PMID: 21279129

Abstract

Treatment of common illnesses in early pregnancy is complicated because of the risk of teratogenic effects of drugs on the fetus. The period of greatest risk is between the first and eighth week of pregnancy. Since much of this period occurs before a diagnosis of pregnancy is made, care must be used in treatment of common illnesses in all women susceptible to becoming pregnant. Few, if any, drugs have been tested for teratogenicity in controlled clinical trials. Risk must therefore be based on epidemiological studies, individual case reporting and extrapolation from animal studies. Sufficient information is available on commonly used drugs to establish such risks. It is important that drugs of least known risk but adequate efficacy be used in treating intercurrent illness in the first trimester.

Full text

PDF
2133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen R. W., Jr, Ogden B., Bentley F. L., Jung A. L. Fetal hydantoin syndrome, neuroblastoma, and hemorrhagic disease in a neonate. JAMA. 1980 Sep 26;244(13):1464–1465. [PubMed] [Google Scholar]
  2. Annegers J. F., Hauser W. A., Elveback L. R., Anderson V. E., Kurland L. I. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol. 1978 Sep;7(3):241–247. doi: 10.1093/ije/7.3.241. [DOI] [PubMed] [Google Scholar]
  3. BONGIOVANNI A. M., McPADDEN A. J. Steroids during pregnancy and possible fetal consequences. Fertil Steril. 1960 Mar-Apr;11:181–186. doi: 10.1016/s0015-0282(16)33723-2. [DOI] [PubMed] [Google Scholar]
  4. Benke P. J. The isotretinoin teratogen syndrome. JAMA. 1984 Jun 22;251(24):3267–3269. [PubMed] [Google Scholar]
  5. Bracken M. B., Holford T. R. Exposure to prescribed drugs in pregnancy and association with congenital malformations. Obstet Gynecol. 1981 Sep;58(3):336–344. [PubMed] [Google Scholar]
  6. Byer A. J., Traylor T. R., Semmer J. R. Acetaminophen overdose in the third trimester of pregnancy. JAMA. 1982 Jun 11;247(22):3114–3115. [PubMed] [Google Scholar]
  7. Collins E., Turner G. Maternal effects of regular salicylate ingestion in pregnancy. Lancet. 1975 Aug 23;2(7930):335–338. doi: 10.1016/s0140-6736(75)92777-4. [DOI] [PubMed] [Google Scholar]
  8. Czeizel A. Letter: Diazepam, phenytoin, and aetiology of cleft lip and/or cleft palate. Lancet. 1976 Apr 10;1(7963):810–810. doi: 10.1016/s0140-6736(76)91654-8. [DOI] [PubMed] [Google Scholar]
  9. Dalens B., Raynaud E. J., Gaulme J. Teratogenicity of valproic acid. J Pediatr. 1980 Aug;97(2):332–333. doi: 10.1016/s0022-3476(80)80517-8. [DOI] [PubMed] [Google Scholar]
  10. Di Battista C., Laudizi L., Tamborino G. Focomelia ed agenesia del pene in neonato. Possible ruolo teratogeno di un farmaco assunto dalla madre in gravidanza. Minerva Pediatr. 1975 Mar 31;27(11):675–679. [PubMed] [Google Scholar]
  11. Gonzalez Ochoa A. Trimethoprim and sulfamethoxazole in pregnancy. JAMA. 1971 Aug 30;217(9):1244–1244. doi: 10.1001/jama.217.9.1244b. [DOI] [PubMed] [Google Scholar]
  12. Hall J. G., Pauli R. M., Wilson K. M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980 Jan;68(1):122–140. doi: 10.1016/0002-9343(80)90181-3. [DOI] [PubMed] [Google Scholar]
  13. Hernandez E., Angell C. S., Johnson J. W. Asthma in pregnancy: current concepts. Obstet Gynecol. 1980 Jun;55(6):739–743. [PubMed] [Google Scholar]
  14. KING C. T. Teratogenic effects of meclizine hydrochloride on the rat. Science. 1963 Jul 26;141(3578):353–355. doi: 10.1126/science.141.3578.353. [DOI] [PubMed] [Google Scholar]
  15. Korcok M. The Bendectin debate. Can Med Assoc J. 1980 Nov 8;123(9):922–928. [PMC free article] [PubMed] [Google Scholar]
  16. Meyer J. G. The teratological effects of anticonvulsants and the effects on pregnancy and birth. Eur Neurol. 1973;10(3):179–190. doi: 10.1159/000114274. [DOI] [PubMed] [Google Scholar]
  17. Myhre S. A., Williams R. Teratogenic effects associated with maternal primidone therapy. J Pediatr. 1981 Jul;99(1):160–162. doi: 10.1016/s0022-3476(81)80986-9. [DOI] [PubMed] [Google Scholar]
  18. Nelson M. M., Forfar J. O. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J. 1971 Mar 6;1(5748):523–527. doi: 10.1136/bmj.1.5748.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nichols M. M. Fetal anomalies following maternal trimethadione ingestion. J Pediatr. 1973 May;82(5):885–886. doi: 10.1016/s0022-3476(73)80089-7. [DOI] [PubMed] [Google Scholar]
  20. Paulson G. W., Paulson R. B. Teratogenic effects of anticonvulsants. Arch Neurol. 1981 Mar;38(3):140–143. doi: 10.1001/archneur.1981.00510030034003. [DOI] [PubMed] [Google Scholar]
  21. Rosenberg L., Mitchell A. A., Parsells J. L., Pashayan H., Louik C., Shapiro S. Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med. 1983 Nov 24;309(21):1282–1285. doi: 10.1056/NEJM198311243092103. [DOI] [PubMed] [Google Scholar]
  22. Rumeau-Rouquette C., Goujard J., Huel G. Possible teratogenic effect of phenothiazines in human beings. Teratology. 1977 Feb;15(1):57–64. doi: 10.1002/tera.1420150108. [DOI] [PubMed] [Google Scholar]
  23. Safra M. J., Oakley G. P., Jr Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet. 1975 Sep 13;2(7933):478–480. doi: 10.1016/s0140-6736(75)90548-6. [DOI] [PubMed] [Google Scholar]
  24. Saxén I. Epidemiology of cleft lip and palate. An attempt to rule out chance correlations. Br J Prev Soc Med. 1975 Jun;29(2):103–110. [PMC free article] [PubMed] [Google Scholar]
  25. Stånge L., Carlström K., Eriksson M. Hypervitaminosis a in early human pregnancy and malformations of the central nervous system. Acta Obstet Gynecol Scand. 1978;57(3):289–291. doi: 10.3109/00016347809154901. [DOI] [PubMed] [Google Scholar]
  26. TUCHMANN-DUPLESSIS H., MERCIER-PAROT L. [Action of cyclizine hydrochloride on the gestation and the embryonic development of the rat, mouse and rabbit]. C R Hebd Seances Acad Sci. 1963 Apr 8;256:3359–3362. [PubMed] [Google Scholar]
  27. WHEATLEY D. DRUGS AND THE EMBRYO. Br Med J. 1964 Mar 7;1(5383):630–630. doi: 10.1136/bmj.1.5383.630-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wilson J. G., Brent R. L. Are female sex hormones teratogenic? Am J Obstet Gynecol. 1981 Nov 1;141(5):567–580. doi: 10.1016/s0002-9378(15)33279-8. [DOI] [PubMed] [Google Scholar]
  29. Yerushalmy J., Milkovich L. Evaluation of the teratogenic effect of meclizine in man. Am J Obstet Gynecol. 1965 Oct 15;93(4):553–562. doi: 10.1016/0002-9378(65)90515-6. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES